fda ghk-cu immunogenicity risk adds non-injectable back to Category 1. FDA Thursday re-added Can doctors prescribe research grade

With proper sterile technique, you can continue sampling from the same vial for 3+ months the standard "discard after 28 days" disclaimer is an FDA bacteriostatic labeling requirement, not a reflection of peptide efficacy

Factors affecting response include: Duration of hair loss (recent loss responds better than long-standing)

There are lots of others, with names like TB-4, TB-500, CJC-1295, ipamorelin, tesamorelin, and GHK-Cu

"Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging"

Collection of fractions every 10-30 min for LC-MS/MS or HPLC quantification

GHK-Cu peptide therapy represents one of those solutions, backed by solid mechanistic science and decades of research, that mainstream medicine ignores because theres no patent profit in a naturally occurring peptide